Bausch Health Companies Inc (BHC) Stock Price

BHCStock

$6.32−10.68%52W

Market Cap$2.36B

P/E14.73x

PEG Ratio0.01

Div yield—

Beta0.59

BHC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-5.89%

Price vs S&P 500 (4W)-10.56%

PEG Ratio0.01

VGM Score63.10

P/E Ratio (Annual)14.73x

P/CF (Annual)1.65x

Book Value / Share (Quarterly)$1.51

P/TBV (Annual)87.73x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)8.11%

Cash Flow / Share (Quarterly)$3.73

Price vs S&P 500 (YTD)-19.86%

Gross Margin (TTM)71.82%

Net Profit Margin (TTM)-10.12%

EPS (TTM)$-2.96

10-Day Avg Trading Volume0.82M

EPS Excl Extra (TTM)$-2.96

Revenue Growth (5Y)5.04%

EPS (Annual)$0.42

ROI (Annual)-2.29%

Gross Margin (Annual)70.65%

Net Profit Margin (5Y Avg)-3.94%

Cash / Share (Quarterly)$4.88

P/E Basic Excl Extra (TTM)13.34x

Revenue Growth QoQ (YoY)12.73%

P/E Normalized (Annual)14.73x

ROA (Last FY)0.60%

Revenue Growth TTM (YoY)10.09%

EBITD / Share (TTM)$4.87

ROE (5Y Avg)-91.99%

Operating Margin (TTM)8.00%

Cash Flow / Share (Annual)$2.68

P/B Ratio4.32x

P/B Ratio (Quarterly)12.58x

Net Income / Employee (Annual)$7,700

EV / Revenue (TTM)1.96x

Net Interest Coverage (TTM)1.23x

ROA (TTM)-4.29%

EPS Growth QoQ (YoY)72.02%

EV / EBITDA (TTM)11.67x

EPS Incl Extra (Annual)$0.42

Current Ratio (Annual)1.47x

Quick Ratio (Quarterly)0.90x

3-Month Avg Trading Volume0.61M

52-Week Price Return-10.68%

EV / Free Cash Flow (Annual)21.42x

P/E Incl Extra (TTM)13.34x

Revenue / Employee (TTM)$534,600

Tangible BV / Share (Quarterly)$0.61

P/S Ratio (Annual)0.23x

Asset Turnover (Annual)0.39x

52-Week High$11.08

Operating Margin (5Y Avg)13.50%

EPS Excl Extra (Annual)$0.42

CapEx CAGR (5Y)5.66%

Tangible BV CAGR (5Y)-21.06%

26-Week Price Return6.04%

Quick Ratio (Annual)0.88x

13-Week Price Return17.38%

Total Debt / Equity (Annual)44.72x

Current Ratio (Quarterly)1.44x

Enterprise Value$21.27B

Revenue / Share Growth (5Y)3.90%

Asset Turnover (TTM)0.42x

Book Value / Share Growth (5Y)-38.57%

Revenue / Employee (Annual)$505,700

Inventory Turnover (Annual)1.87x

Pretax Margin (Annual)3.57%

Cash / Share (Annual)$3.53

3-Month Return Std Dev79.25%

Gross Margin (5Y Avg)71.01%

Net Income / Employee (TTM)$-54,100

EBITDA CAGR (5Y)5.64%

EBITDA Interim CAGR (5Y)84.61%

ROE (Last FY)-104.67%

Net Interest Coverage (Annual)0.54x

EPS Basic Excl Extra (Annual)$0.42

P/FCF (TTM)1.66x

Receivables Turnover (TTM)4.85x

EV / Free Cash Flow (TTM)15.27x

Total Debt / Equity (Quarterly)44.72x

EPS Incl Extra (TTM)$-2.96

Receivables Turnover (Annual)4.57x

ROI (TTM)-2.25%

P/S Ratio (TTM)0.21x

Pretax Margin (5Y Avg)-2.57%

Revenue / Share (Annual)$27.38

Tangible BV / Share (Annual)$0.12

Forward P/E1.43x

Free OCF CAGR (5Y)4.37%

Price vs S&P 500 (52W)-29.24%

P/E Ratio (TTM)13.34x

Year-to-Date Return-7.87%

5-Day Price Return-4.88%

EPS Normalized (Annual)$0.42

ROA (5Y Avg)-1.17%

Net Profit Margin (Annual)1.53%

Month-to-Date Return-9.02%

Cash Flow / Share (TTM)$1.20

EBITD / Share (Annual)$7.94

Operating Margin (Annual)19.24%

LT Debt / Equity (Annual)44.72x

P/CF (TTM)1.28x

ROI (5Y Avg)-4.82%

P/E Excl Extra (TTM)13.34x

LT Debt / Equity (Quarterly)44.72x

EPS Basic Excl Extra (TTM)$-2.96

P/TBV (Quarterly)24.04x

P/B Ratio (Annual)12.58x

Inventory Turnover (TTM)1.88x

Pretax Margin (TTM)-6.74%

Book Value / Share (Annual)$1.51

Price vs S&P 500 (13W)15.43%

Beta0.59x

P/FCF (Annual)2.33x

Revenue / Share (TTM)$28.70

ROE (TTM)-96.76%

52-Week Low$6.10

vGradeB

gGradeC

mGradeC

vgmGradeB

BHC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	$1.01	$1.26	+25.12%(+$0.25)
Q1 2026	Apr 29, 2026	$0.69	$0.78	+12.81%(+$0.09)
Q4 2025	Feb 18, 2026	$1.26	$1.10	-12.85%(-$0.16)
Q3 2025	Oct 29, 2025	$1.06	$1.16	+10.00%(+$0.11)
Q2 2025	Jul 30, 2025	$0.94	$0.91	-4.09%(-$0.04)

BHC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.44

2.38

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
BHCBausch Health Companies Inc	B	C	C	$6.32
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Bausch Health Companies Inc

Bausch Health Companies is a diversified global pharmaceutical and medical device company focused on specialty care markets including gastroenterology, hepatology, neurology, and dermatology. Revenue is driven by its portfolio of branded products across Bausch + Lomb (eye care, largest segment), Salix (gastroenterology), Solta Medical (aesthetics), and other diversified products.